Ludmillenstift, Brustzentrum Trials

Ludmillenstift, Brustzentrum	Welcome, Profile Billing Logout

Ludmillenstift, Brustzentrum

Welcome, Profile Billing Logout

0 Trials

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Fahl, Uta

NCT04101851: Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients with RCR and PCR in the Breast After NAST

Active, not recruiting

N/A

350

Europe

omission of SLNB

Toralf Reimer, MD PhD, European Breast Cancer Reseach Association of Surgical Trialists, University Medicine Rostock, Rostock, Germany (sponsor), Else Kröner-Fresenius-Stiftung (funding), German Society of Senology (funding)

Breast Cancer Female, Breast Cancer

01/28

Nolte, Agnieszka

NCT04101851: Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients with RCR and PCR in the Breast After NAST

Active, not recruiting

N/A

350

Europe

omission of SLNB

Breast Cancer Female, Breast Cancer

01/28

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Fahl, Uta

NCT04101851: Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients with RCR and PCR in the Breast After NAST

Active, not recruiting

N/A

350

Europe

omission of SLNB

Breast Cancer Female, Breast Cancer

01/28

Nolte, Agnieszka

NCT04101851: Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients with RCR and PCR in the Breast After NAST

Active, not recruiting

N/A

350

Europe

omission of SLNB

Breast Cancer Female, Breast Cancer

01/28

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites